CS logo
small CS logo
Dragonboat Biopharmaceutical,Co.,Ltd

Shanghai, Shanghai, China

About Dragonboat Biopharmaceutical,Co.,Ltd


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Dragonboat Biopharmaceutical,Co.,Ltd


During the past decade, Dragonboat Biopharmaceutical,Co.,Ltd conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Dragonboat Biopharmaceutical,Co.,Ltd" #1 collaborator was "West China Hospital" with 2 trials as a collaborator, "Fudan University" with 1 trials as a collaborator and "Shanghai East Hospital" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

Clinical Trials Conditions at Dragonboat Biopharmaceutical,Co.,Ltd


According to Clinical.Site data, the most researched conditions in "Dragonboat Biopharmaceutical,Co.,Ltd" are "Advanced Tumors" (2 trials), "Advanced Malignant Tumor" (1 trials), "Advanced Penile Carcinoma" (1 trials), "Advanced Solid Tumors (Including GCTTS)" (1 trials) and "Bladder Cancer" (1 trials). Many other conditions were trialed in "Dragonboat Biopharmaceutical,Co.,Ltd" in a lesser frequency.

Clinical Trials Intervention Types at Dragonboat Biopharmaceutical,Co.,Ltd


Most popular intervention types in "Dragonboat Biopharmaceutical,Co.,Ltd" are "Drug" (5 trials). Other intervention types were less common.
The name of intervention was led by "BC006" (1 trials), "CDP1" (1 trials), "Human Anti-PD-L1 Monoclonal Antibody Injection (LDP)" (1 trials), "Human Anti-PD-L1 Monoclonal Antibody Injection (LDP) Combined with Recombinant Anti-EGFR Human Mouse Chimeric Monoclonal Antibody Injection (CDP1)" (1 trials) and "Whole Human Anti-PD-L1 Antibody Injection (LDP)" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Dragonboat Biopharmaceutical,Co.,Ltd


The vast majority of trials in "Dragonboat Biopharmaceutical,Co.,Ltd" are 5 trials for "All" genders.

Clinical Trials Status at Dragonboat Biopharmaceutical,Co.,Ltd


Currently, there are NaN active trials in "Dragonboat Biopharmaceutical,Co.,Ltd". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Dragonboat Biopharmaceutical,Co.,Ltd, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Dragonboat Biopharmaceutical,Co.,Ltd, 4 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".